The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19- bone marrow cells

Experimental Hematology

Volumn 28, Issue 2, 2000, Pages 169-176

  Stillman, Wayne S ^a   Varella Garcia, Marileila ^a   Irons, Richard D ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myelogenous leukemia; Benzene; Chromosome aberrations; Hydroquinone; Myelodysplastic syndrome

Indexed keywords

BENZENE DERIVATIVE; HYDROQUINONE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CENTROMERE; CHROMOSOME 5; CHROMOSOME ABERRATION; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; TRISOMY 18;

BENZENE; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 8; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROQUINONES; LEUKEMIA, MYELOCYTIC, ACUTE; MUTAGENS; MYELODYSPLASTIC SYNDROMES; SEQUENCE DELETION;

EID: 0033982687     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00144-7     Document Type: Article

References (48)

1. Vigliani E.C., Saita G. Benzene and leukemia. N Engl J Med. 271:1964;872.
2. Vigliani E.C., Forni A. Benzene and leukemia. Environ Res. 11:1976;122.
3. Aksoy M., Erdem S., Dinçol K., Hepyüksel T., Dinçol G. Chronic exposure to benzene as a possible contributary etiologic factor in Hodgkin's disease. Blut. 28:1974;293.
4. Aksoy M., Erdem S., Dinçol G. Types of leukemia in chronic benzene poisoning. a study in thirty-four patients Acta Haematol. 55:1976;65.
5. Infante P.F., Rinsky R.A., Wagoner J.K., Young R.J. Leukaemia in benzene workers. Lancet. 2:1977;76.
6. Mitelman F., Nilsson P.G., Brandt L., Alimena G., Gastaldi R., Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 4:1981;197.
7. Mitelman F., Brandt L., Nilsson P.G. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood. 52:1978;1229.
8. Golomb H.M., Alimena G., Rowley J.D., Vardiman J.W., Testa J.R., Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 60:1982;404.
9. Narod S.A., Dube I.D. Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 38:1989;261.
10. Van den Berghe H., Louwagie A., Broeckaert-Van Orshoven A., David G., Verwilghen R. Chromosome analysis in two unusual malignant blood disorders presumably induced by benzene. Blood. 53:1979;558.
11. Zhang LP, Rothman N, Wang YX, Hayes RB, Li GL, Dosemeci M, Yin SN, Kolachana P, Titenko-Holland N, Smith MT (1998) Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis 19:1955.
12. Crane M.M., Keating M.J., Trujillo J.M., Labarthe D.R., Frankowski R.F. Environmental exposures in cytogenetically defined subsets of acute nonlymphocytic leukemia. JAMA. 262:1989;634.
13. Le Beau M.M., Rowley J.D. Chromosomal abnormalities in leukemia and lymphoma. clinical and biological significance Adv Hum Genet. 15:1986;1.
14. Andrews L.S., Lee E.W., Witmer C.M., Kocsis J.J., Snyder R.S. Effects of toluene on the metabolism, disposition and hemopoietic toxicity of benzene. Biochem Pharmacol. 26:1977;293.
15. 3H-benzene metabolism in rabbit bone marrow. Life Sci. 25:1979;567.
16. Sammett D., Lee E.W., Kocsis J.J., Snyder R. Partial hepatectomy reduced both metabolism and toxicity of benzene. J Toxicol Environ Health. 5:1979;785.
17. Eastmond D.A., Smith M.T., Irons R.D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol. 91:1987;85.
18. Rickert D.E., Baker T.S., Bus J.S., Barrow C.S., Irons R.D. Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol. 49:1979;417.
19. Wierda D., Irons R.D. Hydroquinone and catechol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone marrow. Immunopharmacology. 4:1982;41.
20. Irons R.D. Quinones as toxic metabolites of benzene. J Toxicol Environ Health. 16:1985;673.
21. Yager J.W., Eastmond D.A., Robertson M.L., Pardisin W.M., Smith M.T. Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res. 50:1990;393.
22. Marrazzini A., Chelotti L., Barrai I., Loprieno N., Barale R. In vivo genotoxic interactions among three phenolic benzene metabolites. Mutat Res Genet Toxicol Testing. 341:1994;29.
23. Stillman W.S., Varella-Garcia M., Gruntmeir J.J., Irons R.D. The benzene metabolite, hydroquinone, induces dose-dependent hypoploidy in a human cell line. Leukemia. 11:1997;1540.
24. Zhang L.P., Wang Y.X., Shang N., Smith M.T. Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes. Leuk Res. 22:1998;105.
25. Foon K.A., Champlin R.E., Gale R.P. Acute myelogenous leukemia and the myelodysplastic syndromes. Haskell C.M. Cancer treatment. 1990;WB Saunders, Philadelphia. 589-606pp.
26. + acute leukemia. Blood. 86:1995;60.
27. + cells Blood. 85:1995;194.
28. Kroef M.J.P.L., Fibbe W.E., Mout R., Jansen R.P.M., Haak H.L., Wessels J.W., Van Kamp H., Willemze R., Landegent J.E. Myeloid but not lymphoid cells carry the 5q deletion. polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions Blood. 81:1993;1849.
29. + subpopulations. Blood. 86:1995;2906.
30. + subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Leukemia. 11:1997;674.
31. - subpopulation of acute myeloid leukemia. Blood. 87:1996;2187.
32. Draper NP, Smith, H (1981) Applied regression analysis, 2nd ed. New York: John Wiley and Sons.
33. Fairman J., Chumakov I., Chinault A.C., Nowell P.C., Nagarajan L. Physical mapping of the minimal region of loss in 5q-chromosome. Proc Natl Acad Sci U S A. 92:1995;7406.
34. Le Beau M.M., Espinosa R. III, Neuman W.L., Stock W., Roulston D., Larson R.A., Keinanen M., Westbrook C.A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci U S A. 90:1993;5484.
35. Horrigan S.K., Westbrook C.A., Kim A.H., Banerjee M., Stock W., Larson R.A. Polymerase chain reaction-based diagnosis of del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood. 88:1996;2665.
36. Van den Berghe H., Vermaelen K., Mecucci C., Barbieri D., Tricot G. The 5q- anomaly. Cancer Genet Cytogenet. 17:1985;189.
37. Le Beau M.M., Albain K.S., Larson R.A., Vardiman J.W., Davis E.M., Blough R.R., Golomb H.M., Rowley J.D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia. further evidence for characteristic abnormalities of chromosomes no. 5 and 7 J Clin Oncol. 4:1986;325.
38. Eastmond D.A., Rupa D.S., Hasegawa L.S. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat Res. 322:1994;9.
39. Paweletz N, Ghosh S, Vig BK (1989) Mitosis and the induction of aneuploidy. In: Mechanisms of Chromosome Distribution. New York: Alan R. Liss, Inc., pp. 217-229.
40. + normal human hematopoietic cells. Blood. 82:1993;2069.
41. Schattenberg D.G., Stillman W.S., Gruntmeir J.J., Helm K.M., Irons R.D., Ross D. Peroxidase activity in murine and human hematopoietic progenitor cells. Potential relevance to benzene-induced toxicity. Mol Pharmacol. 46:1994;346.
42. Kettle A.J., Winterbourn C.C. Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone. J Biol Chem. 267:1992;8319.
43. Irons R.D., Neptun D.A. Effects of the principal hydroxy-metabolites of benzene on microtubule polymerization. Arch Toxicol. 45:1980;297.
44. Pfeifer R.W., Irons R.D. Alteration of lymphocyte function by quinones through a sulfhydryl-dependent disruption of microtubule assembly. Int J Immunopharmacol. 5:1983;463.
45. Eastmond D.A., Schuler M., Rupa D.S. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat Res. 348:1995;153.
46. Irons R.D., Stillman W.S. Impact of benzene metabolites on differentiation of bone marrow progenitor cells. Environ Health Perspect. 104(suppl. 6):1996;1247.
47. Irons R.D., Stillman W.S. The process of leukemogenesis. Environ Health Perspect. 104(suppl. 6):1996;1239.
48. Irons R.D., Stillman W.S. Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells. 11:1993;235.